07:00 , Mar 30, 2015 |  BC Week In Review  |  Clinical News

Anavex Life Sciences Corp preclinical data

In a mouse model of AD, ANAVEX 3-71 reversed synaptic loss in hippocampal neurons. ANAVEX 3-71 also reduced soluble and insoluble beta amyloid 40, beta amyloid 42, beta amyloid plaques and beta-site...
07:00 , Apr 7, 2014 |  BC Week In Review  |  Company News

Anavex, Israel Institute for Biological Research (IIBR) deal

IIBR's Life Science Research Israel Ltd. subsidiary granted Anavex exclusive, worldwide development and commercialization rights to AF710B and additional backup compounds. The sigma-1 receptor and muscarinic acetylcholine receptor M1 ( CHRM1; ...